Financial results - CARABU MEDICAL SRL

Financial Summary - Carabu Medical Srl
Unique identification code: 36014856
Registration number: J40/6202/2016
Nace: 4774
Sales - Ron
167.955
Net Profit - Ron
65.536
Employee
2
The most important financial indicators for the company Carabu Medical Srl - Unique Identification Number 36014856: sales in 2023 was 167.955 euro, registering a net profit of 65.536 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al articolelor medicale si ortopedice, in magazine specializate having the NACE code 4774.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Carabu Medical Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 21.182 124.776 120.501 121.698 125.662 114.935 154.312 167.955
Total Income - EUR - - 21.182 124.865 120.742 121.826 126.105 114.938 154.320 168.419
Total Expenses - EUR - - 12.082 60.359 57.856 80.327 89.935 85.947 101.771 101.203
Gross Profit/Loss - EUR - - 9.100 64.506 62.886 41.499 36.170 28.990 52.549 67.216
Net Profit/Loss - EUR - - 8.464 62.759 61.682 40.282 34.993 27.841 51.006 65.536
Employees - - 1 0 4 4 5 5 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 9.2%, from 154.312 euro in the year 2022, to 167.955 euro in 2023. The Net Profit increased by 14.686 euro, from 51.006 euro in 2022, to 65.536 in the last year.

Check the financial reports for the company - Carabu Medical Srl

Rating financiar

Financial Rating -
Carabu Medical Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Carabu Medical Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Carabu Medical Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Carabu Medical Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Carabu Medical Srl - CUI 36014856

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 8.972 8.807 16.509 20.091 104.377 98.239 94.728
Current Assets - - 15.606 58.023 58.151 48.988 35.330 32.573 51.712 52.645
Inventories - - 4.132 4.927 22.373 13.323 11.931 15.396 6.813 5.761
Receivables - - 3.682 29.228 14.645 17.291 17.972 8.897 19.097 26.345
Cash - - 7.791 23.869 21.133 18.374 5.427 8.279 25.802 20.538
Shareholders Funds - - 8.509 62.811 61.846 54.374 35.317 42.071 111.423 106.337
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 7.097 4.184 5.112 11.123 20.104 104.985 46.480 46.179
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4774 - 4774"
CAEN Financial Year 4774
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 52.645 euro in 2023 which includes Inventories of 5.761 euro, Receivables of 26.345 euro and cash availability of 20.538 euro.
The company's Equity was valued at 106.337 euro, while total Liabilities amounted to 46.179 euro. Equity decreased by -4.748 euro, from 111.423 euro in 2022, to 106.337 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Carabu Medical Srl

Comments - Carabu Medical Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.